chevron_leftBack
As of 13 June 2026, TegoScience Inc. has a market cap of $66.23M USD, ranking #28507 globally and #1521 in South Korea.
It ranks #2582 in the Healthcare sector, and #920 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$66.23MUSD
100.72B KRW
Enterprise Value
$42.83MUSD
65.37B KRW
Revenue (TTM)
$3.91MUSD
5.94B KRW
EBITDA (TTM)
-$2.54MUSD
-3.87B KRW
Net Income (TTM)
-$4.61MUSD
-7.01B KRW
EBITDA Margin
-65%
Profit Margin
-118%
PS Ratio
17.0
PB Ratio
2.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Saewha Jeon
open_in_new
Founded
2001
Website
tegoscience.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.6% | -5.2% | -3.8% | -17% | -32% | -18% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
191420
테고사이언스(주)
ISIN: KR7191420009
Shares Out.:
Shares Outstanding:
8.007M1
Shares Float:
4.55M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
12,580 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About TegoScience Inc.
TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics quality control services and histology services; and SkinBank, an insurance for cells, as well as engages in cell therapy business. The company was founded in 2001 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
14K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
10K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
8K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
7K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
7K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
7K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
826K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
544K%
|
97.4
|
|
SIX: RO
|
$321.52B
485K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
436K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
415K%
218.9B CHF
|
20.5
|
chevron_leftBack